Angela Aggrey
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 2
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Craig N. MorrellLesley M. ChapmanKristina L. ModjeskiKalyan SrivastavaSara TureDavid FieldHelen W. BoucherJoan R. Butterton
- Journals
- The Journal of Immunology (2 papers)Open Forum Infectious Diseases (2 papers)Blood (1 paper)Clinical Infectious Diseases (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesGermanyTürkiye
In The Last Decade
Angela Aggrey
8 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Applied Microbiology and Biotechnology 141
- Molecular Medicine 271
- Hematology 344
- Internal Medicine 65
- Pharmacology 217
Countries citing papers authored by Angela Aggrey
This map shows the geographic impact of Angela Aggrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Aggrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Aggrey more than expected).
Fields of papers citing papers by Angela Aggrey
This network shows the impact of papers produced by Angela Aggrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Aggrey. The network helps show where Angela Aggrey may publish in the future.
Co-authors
The 25 scholars most cited alongside Angela Aggrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 19 | |
| 2 | 2020 | 19 | |
| 3 | RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections Hit paper breakdown → | 2019 | 284 |
| 4 | 2018 | 3 | |
| 5 | Emerging roles for platelets as immune and inflammatory cells Hit paper breakdown → | 2014 | 532 |
| 6 | 2013 | 54 | |
| 7 | 2012 | 165 | |
| 8 | 2010 | 36 |
About Angela Aggrey
Angela Aggrey is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Hematology, Pharmacology and Immunology, having authored 8 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (4 papers), Platelet Disorders and Treatments (3 papers), Antibiotic Use and Resistance (2 papers), Pneumonia and Respiratory Infections (2 papers), Complement system in diseases (1 paper), T-cell and B-cell Immunology (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (141 citations), Molecular Medicine (271 citations), Hematology (344 citations), Internal Medicine (65 citations) and Pharmacology (217 citations). Angela Aggrey has collaborated with scholars based in United States, Germany and Türkiye. Frequent co-authors include Craig N. Morrell, Lesley M. Chapman, Kristina L. Modjeski, Kalyan Srivastava, Sara Ture, David Field, Helen W. Boucher, Joan R. Butterton, Robert Tipping and Jiejun Du. Their work appears in journals such as The Journal of Immunology, Open Forum Infectious Diseases, Blood, Clinical Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.